FDA Inspection 1053267 — Hexal AG
The FDA completed an inspection of Hexal AG on Mar 29, 2018 in Oberhaching. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 29, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Oberhaching (Germany)
Additional Details
Bioanalytical BA/BE